Clinical Evidence
Demonstrate your product's clinical benefit and drive market access.
Confidently support coverage and purchasing decisions with your clinical evidence.
Bring clarity, credibility, and commercial traction to your product strategy with expert third-party clinical evidence solutions. Whether you’re preparing to launch, navigating postmarket barriers, or trying to stand out in a product category, your approach to generating high-quality clinical evidence is pivotal to product success. Med Safety Board (MSB) offers targeted solutions to help manufacturers align with payer and provider expectations. Each solution is designed to meet different challenges experienced across the product life cycle.
Premarket Clinical Evidence Landscape
Design studies that support market access.
Design clinical studies informed by existing product coverage. Many trials fail to meet payer and provider expectations, limiting coverage and adoption. Our premarket solution helps understand required evidence, review competitor clinical positioning, align endpoints with real-world needs, and avoid missteps. Early insight optimizes programs to appeal to payers and providers, avoiding postlaunch access challenges.
Clinical Evidence Evaluation
Build credibility with trusted and objective third-party validation on your clinical data.
We offer objective, systematic, customized analysis of your product’s clinical data, reflecting how payers and providers evaluate safety, effectiveness, and value. Using key elements of PRISMA and GRADE, we review literature, trials, and safety data, summarizing results in a detailed report for internal, strategic use. This supports market access with credible, third-party analysis that decision-makers trust.
- Gain expert, third-party insights into your product’s clinical, comparative effectiveness, and safety—without payer and provider initiation
- Identify evidence strengths and gaps using structured criteria
- Enhance market access discussions with trusted third-party analysis
Postmarket Clinical Evidence Gap Analysis
It's not just about collecting more data—it's about collecting the right data.
Your FDA-approved product may face market access challenges despite strong clinical data. Payers often deny coverage, and providers may not see clear advantages over existing technologies. This could stem from missing or weak evidence in your value dossier. We assess your evidence against market expectations to identify gaps hindering coverage and adoption. Our insights help identify clinical evidence gaps relative to competitor studies and payer expectations, plan and guide future evidence generation efforts to address objections and highlight clinical value, and improve acceptance among payers and providers through targeted data.
Postmarket Clinical Evidence Comparison
Put your evidence in context—so it's seen, understood, and trusted.
Strong clinical evidence may be undervalued if payers lack the right context, potentially misjudging your product’s strengths or favoring competitors. Our analysis clarifies your product’s clinical evidence standing to help you identify advantages and differentiation opportunities.
- Provide structured, third-party analysis using consistent criteria to help payers and providers compare your product in its category
- Gain strategic insight into your product’s competitive position and clinical evidence priorities
- Inform access discussions and planning with clear, credible comparisons and actionable evidence generation guidance
Why Med Safety Board?
Not sure which solution is right for you? We'll help you evaluate the best approach based on your product's clinical evidence maturity, market challenges, and goals.
Get in Touch
Let's start zeroing in on exactly how we can help.
More Ways We Help
Pre-Market and In-Market Regulatory Support
Streamline regulatory submissions with expert guidance on FDA approvals, device labeling, risk assessments, and tailored compliance support.
Learn More
Insights and Qualitative Research
Collaborate with experts to gather data-driven insights, identify safety concerns, and improve pharmaceutical and device safety.
Learn More